Lyme lymphadenopathy references (not a separate condition)
Błazejewicz-Zawadzińiska M, Brochocka A, Lisińska J, Borowiecki M. [A reprospective analysis of 973 patients with lyme borreliosis in Kuyavian- Pomeranian voivodship in 2000-2005]. [Article in Polish] Przegl Epidemiol. 2012;66(4):581-6. [PubMed]
Tunev SS, Hastey CJ, Hodzic E, Feng S, Barthold SW, Baumgarth N. Lymphoadenopathy during lyme borreliosis is caused by spirochete migration- induced specific B cell activation. PLoS Pathog. 2011;7(5):e1002066.
doi: 10.1371/journal.ppat.1002066. [PubMed]
Vukadinov J1, Canak G, Brkić S, Samardzija NM, Aleksić-Dordević M, Turkulov V, Cik-Nad E, Lalosević V. [Clinico-epidemiologic characteristics of Lyme disease treated at the Infectious Disease in Novy Sad 1993-1998]. [Article in Croatian] Med Pregl. 2001;54(9-10):470-5. [PubMed]
Some definitions of Terminology
✓ The secondary stage results from the dissemination of Borrelia during the early latent stage.
✓ The late stage is considered chronic if the duration is more than six months.
✓ ** (double red asterisks) indicates possibility of fatality from the condition
© Copyright 2017. Global Network on Institutional Discrimination and Ad Hoc Committee for Health Equity in ICD11 Borreliosis Codes All Rights Reserved